Simple Summary In this review, we present current knowledge of sex hormones in the
process of development of malignant diseases. The impact of sex hormones on immune …

Currently, immunotherapy based on PD-1/PD-L1 pathway blockade has improved survival
of non-small cell lung cancer (NSCLC) patients. However, differential responses have been …

Objective This study aimed to identify and project the epidemiological trends and the burden
of lung cancer in China. Methods We extracted incidence, mortality, disability-adjusted life …

Prevalent as a major phenolic ingredient of soy and soy products, genistein is recognized as
an eminent phytoestrogen owing to its interacting ability with estrogen receptors (ERs). The …

Estrogens and their role in cancer are well-studied, and some cancer types are classified in
terms of their response to them. In recent years, a G protein-coupled estrogen receptor …

The prevalence of lung cancer in women currently merits our attentions. However, cigarette
exposure alone does not tell the whole story that lung cancer is more prevalent among non …

Background Women are at greater risk of developing non-small cell lung cancer (NSCLC),
yet the underlying causes remain unclear. Methods We performed whole genome scans in …

Lung adenocarcinoma (LUAD) is a common type of malignant tumor with poor prognosis
and high mortality. In our previous studies, we found that estrogen is an important risk factor …

Importance Sex differences in head and neck cancer (HNC) incidence suggest a potential
contribution of sex hormones. Objective To assess the role of exogenous estrogen exposure …

Our body is constantly exposed to pathogens or external threats, but with the immune
response that our body can develop, we can fight off and defeat possible attacks or …